Medicare limits coverage of $28,000-a-year Alzheimer’s drug

Quebec to force unvaccinated to pay financial penalty
11 January 2022
Resource allocations for health and education should be based on evidence, not politics
12 January 2022

Medicare limits coverage of $28,000-a-year Alzheimer’s drug

Medicare said Tuesday it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned, a major development in the nation’s tug-of-war over the fair value of new medicines that offer tantalizing possibilities but come with prohibitive prices.

Comments are closed.